Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 97,030 | 295,166 | 33,149 | -92,290 | -131,514 |
| Depreciation Amortization | 15,792 | 12,473 | 7,608 | 4,927 | 3,706 |
| Income taxes - deferred | 36,389 | -208,726 | 0 | N/A | N/A |
| Accounts receivable | -59,239 | -36,440 | -31,262 | -49,545 | N/A |
| Other Working Capital | -27,361 | -14,239 | -11,760 | -74,443 | -3,401 |
| Other Operating Activity | 98,295 | 65,607 | 55,464 | 71,737 | 21,295 |
| Operating Cash Flow | $160,906 | $113,841 | $53,199 | $-139,614 | $-109,914 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -76,473 | -19,026 | 9,368 | 39,266 | 119,357 |
| PPE Investments | -12,843 | -35,275 | -39,733 | -68,825 | -31,856 |
| Purchase Sale Intangibles | N/A | -27,740 | -8,624 | N/A | N/A |
| Other Investing Activity | -2 | -27,122 | -8,285 | 32,636 | -33,594 |
| Investing Cash Flow | $-89,318 | $-81,423 | $-38,650 | $3,077 | $53,907 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 18,000 | 26,000 |
| Debt Repayment | 0 | -44,301 | -273 | -161 | -224 |
| Common Stock Issued | 37,546 | 30,733 | 28,893 | 47,005 | 153,827 |
| Common Stock Repurchased | 0 | -1,416 | 0 | N/A | -279 |
| Other Financing Activity | 1,321 | 714 | -312 | 0 | 0 |
| Financing Cash Flow | $38,867 | $-14,270 | $28,308 | $64,844 | $179,324 |
| Exchange Rate Effect | -482 | 1,012 | -166 | 188 | -120 |
| Beginning Cash Position | 157,172 | 138,012 | 95,321 | 166,826 | 43,629 |
| End Cash Position | 267,145 | 157,172 | 138,012 | 95,321 | 166,826 |
| Net Cash Flow | $109,973 | $19,160 | $42,691 | $-71,505 | $123,197 |
| Free Cash Flow | |||||
| Operating Cash Flow | 160,906 | 113,841 | 53,199 | -139,614 | -109,914 |
| Capital Expenditure | -12,843 | -35,275 | -39,733 | -68,825 | -31,856 |
| Free Cash Flow | 148,063 | 78,566 | 13,466 | -208,439 | -141,770 |